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Abstract
Background: Staphylococcus aureus is an important pathogen causing a wide range of infections in the hospital
and community setting. In order to have adequate information for treatment of S. aureus infections, it is crucial to
understand the trends in the antibiotic-resistance patterns. In addition, the occurrence and changes in types of S.
aureus, clonal identities, and their geographic spread is essential for the establishment of adequate infection
control programmes. In this study, 68 S. aureus isolates obtained from clinical and non-clinical sources in Nigeria
between January and April 2009 were characterized using phenotypic and molecular methods.
Results: All the S. aureus isolates were susceptible to teicoplanin, vancomycin, phosphomycin, fusidic acid,
rifampicin, daptomycin, mupirocin, linezolid and tigecycline. Sixteen percent of the isolates were resistant to
oxacillin, while 55% and 72% of isolates were resistant to tetracycline and trimethoprim/sulphamethoxazole
(cotrimoxazole), respectively (Table 1). There was excellent correlation between the broth microdilution assay and
detection of antibiotic resistance genes by the multiplex PCR, in the determination of S. aureus resistance to
erythromycin, gentamicin, methicillin and tetracycline. A total of 28 spa types were identified in the study, and the
predominant spa type among the methicillin-susceptible S. aureus (MSSA) isolates was t084 (13 isolates). The t037-
ST241-SCCmecIII type was the only clone identified in Maiduguri (North-East Nigeria) while in South-West Nigeria,
diversity among the MRSA isolates (t451-ST8-SCCmecV; t008-ST94-SCCmecIV; t002-ST5-SCCmecV; t064-ST8-SCCmecV)
was observed. The toxin genes seh and etd were detected in isolates affiliated with clonal complexes CC1, CC80
and sequence type ST25, respectively. The proportion of PVL-positive isolates among MSSA was high (40%). Most
of the PVL-positive MSSA isolates were obtained from wound infections and associated with clonal complexes CC1,
CC30, CC121 and with sequence type ST152.
Conclusions: The use of phenotypic and molecular methods provided useful information on antibiotic resistance
and molecular diversity of S. aureus in Nigeria. The high proportion of PVL-positive MSSA isolates affiliated to
various clonal complexes and detected in all the health institutions is a major concern, both as a source of severe
infections and as a potential reservoir that could lead to the emergence of PVL-positive MRSA. This study presents
the first baseline information on the nature of the antibiotic resistance genes from S. aureus isolates in Nigeria.
There is the need to curtail the spread and establishment of MRSA and PVL-positive MSSA clones in Nigerian
health care institutions.
Background
Staphylococcus aureus is a leading cause of diseases such
as skin and soft tissue infections, pneumonia, blood-
stream infections, osteomyelitis and endocarditis, as well
as toxin-mediated syndromes like toxic shock and food
poisoning [1,2]. It has developed resistance to a wide
range of antimicrobial drugs, which complicates the
treatment of infections. In particular, methicillin-resis-
tant S. aureus (MRSA) has become a notorious etiologic
agent for a wide variety of infections and it is one of the
most important nosocomial pathogens worldwide [3-6].
Methicillin-susceptible S. aureus (MSSA) become MRSA
through the acquisition and insertion into their genomes
of a large DNA fragment known as staphylococcal chro-
mosome cassette mec (SCCmec), which contains the
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methicillin resistance determinant, mecA [7]. Several
variants of SCCmec have been described, which differ
with respect to the composition of their recombinase
genes and mec gene complex (containing the mecA
gene) [8,9].
In the developing world, mortality associated with
severe S. aureus infections far exceeds that in developed
countries [10,11]. Recent studies have identified S. aur-
eus as the main etiological agent of many infections in
sub-Saharan Africa [12-16], and a number of investiga-
tions have reported that S. aureus is among the most
frequently encountered bacterial species in microbiology
laboratories in Nigeria [17-22]. However, data on the
molecular epidemiology of this pathogen in Nigeria is
very limited. Recent reports have indicated that the pre-
valence of hospital-associated MRSA varies in health
care institutions [23,24]. A community-associated MRSA
clone with a unique resistance profile has also been
reported from South-West Nigeria [25]. To understand
and potentially predict trends in antibiotic-resistance
patterns and to establish adequate infection control pro-
grams, it is crucial to understand the local epidemiology
of S. aureus in Nigeria. Knowledge of the local antimi-
crobial resistance patterns of bacterial pathogens is
essential to guide empirical and pathogen specific ther-
apy. The threat of antibiotic-resistant bacteria has
initiated studies on the nature of genes encoding resis-
tance and the mechanism by which these genes spread
and evolve. Antibiotic susceptibility testing of S. aureus
in Nigeria is based on phenotypic testing especially the
disk diffusion technique but recent studies have relied
on the PCR detection of the mecA gene for the identifi-
cation and confirmation of MRSA [23-26]. However, no
information is available on the nature of antibiotic resis-
tance genes of S. aureus in Nigeria. Our present study
provides baseline information on antibiotic resistance
and molecular epidemiology of MSSA and MRSA in
Nigeria.
Results
Antibiotic susceptibility testing and detection of
antibiotic resistance genes in S. aureus isolates
The 68 S. aureus isolates obtained between January and
April 2009 were analyzed for antimicrobial resistance
(Table 1). All the isolates were susceptible to teicopla-
nin, vancomycin, phosphomycin, fusidic acid, rifampicin,
daptomycin, mupirocin, linezolid and tigecycline, and
two isolates were susceptible to all the antibiotics tested.
In addition to the antibiotics stated above, all MSSA iso-
lates (84%) were susceptible to clindamycin and moxi-
floxacin and less than 4% were resistant to
erythromycin, 21.1% to ciprofloxacin, 47% to tetracy-
cline, 68% to cotrimoxazole and 86% to penicillin. The
predominant antibiotypes among the MSSA isolates
were resistance to penicillin, tetracycline and cotrimoxa-
zole (15 isolates), and resistance to penicillin and cotri-
moxazole (13 isolates). A total of 11 isolates were
resistant to oxacillin and confirmed as MRSA based on
the detection of the mecA gene (Table 1). The ermA
gene was identified in all erythromycin-resistant MRSA
isolates, while two erythromycin-resistant MSSA isolates
possessed the msrA gene. All the gentamicin-resistant
isolates carried the aacA-aphD gene. Moreover, the
tetM gene was detected in 11 isolates (7 MRSA and 4
MSSA) and the tetK gene was present in 4 MRSA and
23 MSSA isolates.
SCCmec typing
The SCCmec type V was identified in four MRSA iso-
lates obtained in Ile-Ife, Ibadan and Lagos, while one
MRSA isolate from Ile-Ife possessed the SCCmec type
IV element (Table 2). The MRSA isolates from Maidu-
guri were non-typeable for the SCCmec element based
on established protocols [9,27], and no amplification
was observed for the ccrA, ccrB, and ccrh genes. How-
ever, these MRSA isolates possessed the ccu gene. The
comparison and analysis of the ccu sequences from two
selected MRSA isolates in this group with sequences in
the GenBank suggested that the MRSA isolates pos-
sessed an SCCmec type III element of uncommon orga-
nization, which had not been identified using standard
protocols.
Table 1 Antibiotic resistance profile of S. aureus (MSSA
and MRSA) from Nigeria
Number (%) of resistant isolates
among:
Antibiotic MSSA
(n = 57)
MRSA
(n = 11)
Total
(n = 68)
Penicillin 49 (86) 11 (100) 60 (88.2)
Oxacillin 0 (0) 11 (100) 11 (16.2)
Teicoplanin 0 (0) 0 (0) 0 (0)
Vancomycin 0 (0) 0 (0) 0 (0)
Gentamicin 1 (1.8) 9 (81.8) 10 (14.7)
Tetracycline 27 (47.4) 11 (100) 38 (55.9)
Ciprofloxacin 12 (21.1) 8 (72.7) 20 (29.4)
Moxifloxacin 0 (0) 7 (63.6) 7 (10.3)
Trimethoprim/sulfamethoxazole 39 (68.4) 10 (90.9) 49 (72.1)
Phosphomycin 0 (0) 0 (0) 0 (0)
Fusidic acid 0 (0) 0 (0) 0 (0)
Erythromycin 2 (3.5) 6 (54.5) 8 (11.8)
Clindamycin 0 (0) 6 (54.5) 6 (8.8)
Rifampicin 0 (0) 0 (0) 0 (0)
Daptomycin 0 (0) 0 (0) 0 (0)
Mupirocin 0 (0) 0 (0) 0 (0)
Linezolid 0 (0) 0 (0) 0 (0)
Tigecycline 0 (0) 0 (0) 0 (0)
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Molecular diversity of S. aureus based on spa typing and
MLST
Twenty-eight spa types were identified in this study.
Representative isolates were subsequently selected for
MLST (Tables 2 and 3). Results indicated that nine
major clonal complexes were represented in our strain
collection from Nigeria (Tables 2 and 3). These clonal
complexes plus one that we did not find (CC22) seem
to predominate the S. aureus population on all conti-
nents. In addition, we found sequence type ST152,
which has been reported previously in Ibadan and Mai-
duguri (Nigeria) [24,25].
Detection of markers frequently associated with
community-acquired S. aureus
A total of 23 of the 57 (40.3%) MSSA isolates (grouped
in clonal complexes - CC1, CC5, CC15, CC30, CC121,
CC80 and sequence type ST152) were PVL positive
(Table 3), while none of the MRSA possessed the PVL
gene. The enterotoxin H gene (seh) was detected in the
isolates from clonal lineage CC1. Three MSSA isolates
(ST25) from nasal samples of healthy individuals and
one MSSA (CC80) from a wound infection possessed
the etd gene. All the S. aureus isolates were arcA
negative.
Discussion
There was excellent correlation between the broth
microdilution method and detection of the genetic
determinants by multiplex PCR for S. aureus resistance
to erythromycin, gentamicin, methicillin and tetracycline
(Tables 2 and 3). About 55% (11 MRSA, 27 MSSA) and
70% (10 MRSA, 39 MSSA) of the S. aureus isolates were
resistant to tetracycline and cotrimoxazole, and as pre-
vious studies from South-West Nigeria had shown
[23,25], it appears that there is a high proportion of S.
aureus isolates resistant to these antibiotics in Nigeria.
Tetracycline and cotrimoxazole historically had wide
clinical application, is inexpensive, orally administered
and available from diverse sources where they are sold
with or without prescription in Nigeria. Moreover, they
are listed in many developing countries as among the
antibacterial agents that have been rendered ineffective,
or for which there are serious concerns regarding bac-
terial resistance [28]. It appears that misuse and overuse
of these antibiotics could have contributed to this trend
in Nigeria. Therefore, to prevent treatment failures in
the absence of data on antibiotic susceptibility testing,
public enlightenment on the ineffectiveness of these
antibiotics against S. aureus infections, and the enact-
ment of effective drug policies in Nigeria are urgently
Table 2 Characterization of MRSA isolates from Nigeria based on antibiotic susceptibility pattern, detection of
antibiotic resistance genes, SCCmec typing, spa typing and MLST
Isolate
No
Location Sample or Clinical
Diagnosis
Antibiotype Antibiotic resistance
genes
SCCmec
type
spa
type
MLST
09-01730 Ile-Ife Chronic ulcer PEN, OXA, GEN, OTE, SXT mecA, aacA-aphD, tetK V t451 8
09-01731 Ile-Ife Urinary tract infection PEN, OXA, GEN, OTE mecA, aacA-aphD, tetM IV t008 94 (8-
slv)
09-01739 Lagos Wound infection PEN, OXA, OTE, CIP, SXT mecA, tetK V t002 5
09-01776 Ibadan Conjunctivitis PEN, OXA, OTE, SXT mecA, tetK V t064 8
09-01786 Ibadan Wound infection PEN, OXA, GEN, OTE, CIP, SXT, MFL mecA, aacA-aphD, tetK V t064 8
09-01789 Maiduguri Wound infection PEN, OXA, GEN, ERY, CLI, OTE, CIP,
SXT, MFL
mecA, aacA-aphD, ermA,
tetM
III t037 241
09-
01791-1
Maiduguri Semen (Infertility) PEN, OXA, GEN, ERY, CLI, OTE, CIP,
SXT, MFL
mecA, aacA-aphD, ermA,
tetM
IIIa t037 241
09-01795 Maiduguri Throat Infection PEN, OXA, GEN, ERY, CLI, OTE, CIP,
SXT, MFL
mecA, aacA-aphD, ermA,
tetM
IIIa t037 ND
09-01809 Maiduguri Semen (Infertility) PEN, OXA, GEN, ERY, CLI, OTE, CIP,
SXT, MFL
mecA, aacA-aphD, ermA,
tetM
IIIa t037 241
09-01811 Maiduguri Wound Infection PEN, OXA, GEN, ERY, CLI, OTE, CIP,
SXT, MFL
mecA, aacA-aphD, ermA,
tetM
IIIa t037 ND
09-01812 Maiduguri Wound Infection PEN, OXA, GEN, ERY, CLI, OTE, CIP,
SXT, MFL
mecA, aacA-aphD, ermA,
tetM
IIIa t037 ND
aSCCmec type inferred from related isolate 09-01789
slv: single locus variant
Geographical region: South-West Nigeria (Ile-Ife, Ibadan and Lagos)
North-East Nigeria (Maiduguri)
KEY
PEN: Penicillin G; OX: Oxacillin; GEN: Gentamicin; ERY: Erythromycin; CLI: Clindamycin; OTE: Tetracycline; CIP: Ciprofloxacin; SXT: Trimethoprim/sulfamethoxazole;
MFL: Moxifloxacin
ND: Not determined
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Table 3 Characterization of MSSA isolates from Nigeria by antibiotic susceptibility pattern, detection of antibiotic and
virulence genes, spa typing and MLST
Isolate
No
Location Sample Or Clinical
Diagnosis
Antibiotype Antibiotic resistance
genes
Toxin
genes
spa
type
MLST Clonal Complex
(CC)
09-01760 Ife Wound Infection PEN, CIP, SXT - lukPV, seh t127 CC1
09-01823 Ife Wound Infection PEN, OTE tetK lukPV, seh t127
09-
01785-1
Ibadan Conjunctivitis PEN - lukPV, seh t114
09-01787 Maiduguri Wound Infection PEN, OTE tetK seh t321 1
09-01733 Ife Otitis media PEN, SXT - lukPV t311 CC5
09-01738 Lagos Urinary tract infection PEN, ERY, OTE, CIP, SXT tetM, mrsA - t311 5
09-01777 Ibadan Wound Infection PEN, CIP - - t311
09-01815 Maiduguri Otitis media PEN, ERY, OTE, SXT tetM, mrsA - t311
09-01737 Lagos Semen (Infertility) PEN, GEN, OTE, SXT aacA-aphD, tetK - t951 CC8
09-01742 Lagos Unknown PEN, OTE tetK - t1617 8
09-01780 Ibadan Conjunctivitis PEN, SXT - - t064
09-01796 Maiduguri Sputum (Unknown) PEN, OTE, SXT tetK - t064
09-01810 Ife Sputum (Unknown) PEN, OTE, CIP, SXT tetK - t1496
09-
01817-1
Maiduguri Urinary tract infection PEN, OTE, SXT tetK - t1496
09-01819 Maiduguri Semen (Infertility) PEN, OTE, SXT tetK - t2812
09-01822 Ife Sputum (Unknown) PEN, OTE, SXT tetK - t1496
09-01734 Ife Unknown PEN, OTE, SXT tetK - t084 CC15
09-01736 Lagos Otitis media OTE tetM - t084
09-01750 Ife Nasal* PEN, SXT - lukPV t084
09-01751 Ife Nasal* PEN, SXT - lukPV t084 15-slv
09-01752 Ife Nasal* SXT - lukPV t084
09-01755 Ife Nasal* PEN, OTE, SXT tetK - t084
09-01756 Ife Nasal* PEN, OTE, CIP, SXT tetK - t084
09-01799 Maiduguri Otitis media PEN, OTE, SXT tetK - t084
09-01801 Maiduguri Otitis media PEN, OTE, SXT tetK - t084
09-01805 Ife Blood Infection OTE tetM - t084 15-slv
09-01820 Ife Wound Infection PEN, SXT - - t084
09-01821 Ife Wound Infection PEN, OTE, SXT tetK - t084
09-01824 Ife Wound Infection CIP, SXT - - t084
09-01788 Maiduguri Wound Infection PEN, OTE, SXT tetK - t2216
09-01798 Maiduguri Semen (Infertility) PEN, OTE, SXT tetK - t2216 15
09-01804 Maiduguri Wound Infection PEN, OTE, SXT tetK - t2216
09-01806 Ife Unknown PEN, SXT - - t328
09-01813 Ife Wound Infection PEN, SXT - - t5387
09-01740 Lagos Wound Infection PEN, CIP, SXT - lukPV t318 CC30
09-01743 Lagos Wound Infection CIP, SXT - lukPV t318 30
09-
01747-2
Lagos Wound Infection Susceptible to all
antibiotics
- lukPV t318 30
09-01779 Ibadan Wound Infection PEN, CIP, SXT - lukPV t021
09-01825 Ife Otitis media PEN, CIP - - t631
09-01732 Ile-Ife Unknown PEN, SXT - lukPV t159 CC121
09-01759 Ile-Ife Wound Infection PEN, SXT - lukPV t314
09-01797 Maiduguri Wound Infection OTE tetK lukPV t314
09-01826 Ile-Ife Otitis media PEN - lukPV t159 121
09-01745 Lagos Semen (Infertility) PEN, SXT - lukPV t2304 121
09-01781 Ibadan Wound Infection PEN, OTE, SXT tetK lukPV t2304
09-01761 Ife Wound Infection PEN - lukPV t355 singleton
09-01762 Ife Wound Infection PEN - lukPV t355
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needed. The predominant mechanism of trimethoprim
resistance in S. aureus appears to be mutation of the
dihydrofolate reductase (DHFR), which is selected even
when trimethoprim is used in combination with sulfa-
methoxazole [29]. In this study, all the trimethoprim-
resistant S. aureus isolates were dfrA negative suggesting
that mutation of the dihydrofolate reductase (DHFR) is
responsible for resistance. Isolates resistant to tetracy-
cline carried either one of the resistance genes tetK or
tetM (Tables 2 and 3), which mediate resistance through
active drug efflux or ribosomoal protection mechanisms,
respectively. This is the first study that provides baseline
information on the nature of the antibiotic resistance
genes from S. aureus isolates in Nigeria. The multiplex
PCR assay was easy to perform, cost-effective and
assisted in the prompt characterization of the resistance
genes stated above. It could be adapted for use by clini-
cal scientists in the referral health care institutions
regarding the antibiotics administered and the prevalent
resistance determinants in Nigeria.
The proportion of PVL-positive isolates among MSSA
was high (40%). Most of the PVL-positive MSSA isolates
were obtained from wound infections and classified in
clonal complexes CC1, CC30, CC121 and ST152. More-
over, the detection of the seh gene in CC1 isolates and
the identification of the etd gene in ST25 and CC80 iso-
lates is in agreement with previous reports [27,30-32].
PVL is frequently associated with severe and recurrent
skin and soft-tissue infections (SSTIs) and has previously
been found in S. aureus isolates from various complexes.
In particular, PVL-producing MSSA affiliated to CC121
are known to be common in many countries on all con-
tinents [30,33,34], including Nigeria, Togo and South
Africa in sub-Saharan Africa [25,30,35]. PVL-positive
ST152 was the predominant clone in a study recently
conducted in North-Eastern Nigeria [24] and it was the
second most prevalent clone in a carriage study from a
West-African country (Mali) [36]. Furthermore, the high
prevalence of PVL positive MSSA ST152 emerging in
the community as well as in hospitals in West Africa
has also been described [31]. Hence, ST152 seems to be
widespread and frequent in West Africa, whereas it is
comparatively rare elsewhere [33,37], in contrast to
many other clonal complexes that display worldwide
occurrence. The luk-PV genes are carried on mobile
genetic elements (prophages), which may be incorpo-
rated into S. aureus lineages through horizontal transfer,
either before or after acquisition of the mecA gene [38].
The high proportion of PVL-positive MSSA observed in
this study indicate that conditions that increase the risk
of inter-individual transmission (e.g skin-to-skin and
skin-to-fomite contacts) could represent important
routes of spread in the various hospital settings. Contact
with colonized and/or infected individuals as well as
contaminated fomites in the spread of PVL positive S.
aureus have been described as risk factors for commu-
nity-associated MRSA [39]. Moreover, the detection of
PVL-positive MSSA ST152 from members of one family
and their relatives with skin infections at the Canary
Island underscore the pathogenic and contagious nature
of this clone [40]. More detailed investigations on the
prevalence of PVL-positive S. aureus are needed in
Africa with respect to (i) nasal carriage of S. aureus in
the hospitals and community, (ii) cross-transmission
from post-operative wound infections acquired during
hospital stay, and (iii) cross-transmission from patients
admitted to the health institutions for treatment of an
SSTI acquired in the community. The detection of PVL-
positive MSSA isolates from the various health institu-
tions, indicating their wide geographical distribution,
Table 3 Characterization of MSSA isolates from Nigeria by antibiotic susceptibility pattern, detection of antibiotic and
virulence genes, spa typing and MLST (Continued)
09-01778 Ibadan Wound Infection PEN, CIP - lukPV t355
09-01790 Maiduguri Wound Infection Susceptible to all
antibiotics
- - t355 152
09-01793 Maiduguri Wound Infection PEN - lukPV t355
09-01803 Maiduguri Wound Infection PEN, OTE, SXT tetK lukPV t355
09-01753 Ife Nasal* PEN, SXT - etd t3772 25 singleton
09-01754 Ife Nasal* PEN, SXT - etd t3772
09-01757 Ife Nasal* PEN, SXT - etd t3772
09-01802 Maiduguri Wound Infection PEN, CIP - - t939 45 CC45
09-01792 Maiduguri Wound Infection PEN, OTE tetK - t458 97 CC97
09-01800 Maiduguri Wound Infection PEN, OTE, SXT tetK lukPV, etd t934 80 CC80
aClonal complex (CC) inferred from MLST and spa typing
*Nasal isolates from apparently healthy male students
slv: single locus variant
Geographical region: South-West Nigeria (Ile-Ife, Ibadan and Lagos)
North-East Nigeria (Maiduguri)
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could pose serious problem in the future as potential
reservoirs for resistance and virulence factors, and could
lead to the emergence and spread of PVL-positive
MRSA clones in Nigeria causing severe infections. This
could have important implications for the enactment of
effective infection control guidelines.
MRSA has become a major public health problem
worldwide and recent reports have indicated that the
prevalence of hospital-associated MRSA (based on the
detection of the mecA gene) in health care institutions
in Nigeria may vary from 1.5% to 20% [23-25]. All the
MRSA isolates obtained from Maiduguri (North-East
Nigeria) had the same spa type (t037) and MLST pro-
file (ST241), identical to isolates from the same region
that had been investigated in a previous study [24].
Another study [25] also reported that the clone was
identified in a hospital in Ibadan (South-Western
Nigeria). ST241 is a single locus variant (slv) of the
ST239 clone, which is prevalent in South East Asia
and has also been reported from Europe, the Americas
[41], and several countries in Africa [6,42-44]. The
multi-resistant nature of this MRSA clone could be
explained by the presence of several resistance genes
in the SCCmec cassette and it was recently shown to
have spread across several continents since the 1960s
[41]. MRSA ST239 demonstrating low level resistance
to glycopeptides have been reported recently in Russia
[45] and New Zealand [46]. In contrast, in South-Wes-
tern Nigeria, we identified more diversity among the
MRSA isolates. In three different hospitals in this
region, we observed several different clones of MRSA
that can be distinguished on the basis of MLST,
SCCmec typing and spa typing, and displayed distinct
antimicrobial resistance profiles (Table 2).
Conclusions
This study showed that the combination of susceptibility
testing and various molecular methods provided useful
information on the antibiotic resistance and molecular
diversity of S. aureus in Nigeria. Although the number
of S. aureus isolates available for our investigation and
epidemiological information was limited, the high pro-
portion of PVL-positive MSSA observed in this study
indicate that adequate measures are needed to curtail
the spread and establishment of MRSA and PVL-posi-
tive MSSA clones in Nigerian health care institutions.
Methods
Isolation and identification of S. aureus isolates
In this study, a total of 68 non-duplicate consecutive S.
aureus isolates (60 - clinical isolates; 8 - nasal isolates;
one isolate per sample per individual) obtained between
January and April 2009 were characterized. The clinical
isolates were obtained from samples processed in the
microbiology laboratories of referral health care institu-
tions in Ile-Ife, Ibadan and Lagos (South-West Nigeria),
and Maiduguri (North-East Nigeria), each of which are
500-bed facilities providing medical care to about one
million people. The clinical isolates were cultured from
30 males (median age: 31 years, range: 1 year-70 years),
21 females (median age: 36 years, range: 1 week-63
years) and 9 unknown gender. In addition, nasal isolates
were obtained from apparently healthy male undergrad-
uate students in Ile-Ife. The origin and characteristics of
each isolate is stated in Tables 2 and 3. The isolates
were cultured on sheep blood agar and phenotypic iden-
tification of S. aureus was based on colony morphology
and positive plasma coagulase reaction (slide and tube
test). The susceptibility testing of the isolates to 18 anti-
biotics was performed using the broth microdilution
assay as described by Deutsches Institut für Normung
[47]. The antibiotic panel included penicillin G, oxacil-
lin, teicoplanin, vancomycin, gentamicin, tetracycline,
ciprofloxacin, moxifloxacin, trimethoprim/sulfamethoxa-
zole (cotrimoxazole), phosphomycin, fusidic acid, ery-
thromycin, clindamycin, rifampicin, daptomycin,
mupirocin, linezolid and tigecycline.
DNA extraction
Genomic DNA was obtained from a 2 ml overnight cul-
ture using a DNeasy tissue kit (Qiagen, Hilden, Ger-
many) with lysostaphin (100 μg/ml) to achieve bacterial
lysis.
PCR detection of the tuf gene
Phenotypic identification of the S. aureus isolates was
confirmed by the detection of the tuf gene [48].
Multiplex PCR for detection of antibiotic resistance genes
The antibiotic resistance determinants investigated
were the aac-aphD (aminoglycoside resistance) mecA
(methicillin resistance) ermA, ermC (erythromycin
resistance) and tetK, tetM (tetracycline resistance)
genes. PCR primers and conditions were as described
in a previously established protocol [49]. Moreover, the
detection of the dfrA and msrA genes (trimethoprim
resistance and macrolide efflux resistance determi-
nants) were investigated using the following primers
tmpI: CTC ACG ATA AAC AAA GAG TCA; tmp II:
CAA TCA TTG CTT CGT ATA ACG and msrA f:
GAA GCA CTT GAG CGT TCT; msrA r: CCT TGT
ATC GTG TGA TGT which amplified a 201bp and
287bp of the dfr and msrA genes, respectively. The
PCR conditions were as follows: Initial denaturation at
95°C for 2 minutes followed by 30 cycles of amplifica-
tion with 94°C for 30 seconds, annealing at 50°C for
30 seconds, extension at 72°C for 30 seconds and final
extension at 72°C for 4 minutes.
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Multiplex PCR for detection of markers associated with
community-acquired S. aureus
A multiplex PCR reaction protocol [27] was used to
detect markers associated with community-acquired S.
aureus. They included the enterotoxin H gene (seh) for
community-acquired S. aureus of clonal lineage ST1/
USA400, the arginine deiminase gene (arcA) as part of
the ACME (arginine catabolic mobile element) cluster
for ST8/t008/USA300, the gene for exfoliative toxin D
(etd) for ST80, and the Panton-Valentine Leukocidin
(PVL) gene.
SCCmec typing
SCCmec elements were classified by the multiplex PCR
strategy [9,50]. SCCmec elements that could not be
typed were characterized based on PCR amplification
and sequence analysis of the cassette chromosome
recombinases A and B genes (ccrA, ccrB), cassette chro-
mosome helicase (cch) and another gene of unknown
function (ccu) [51].
Spa typing
Spa typing was based on the method described pre-
viously [52]. The nucleotide sequences were analyzed
using the RIDOM Staph-Type software (Ridom GmbH,
Germany) to assign the isolates to the various spa types.
Multilocus sequence typing (MLST)
MLST was performed according to the previously pub-
lished protocol [53].
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